# NeuroBlate System

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/neuroblate-system-gex-k141983>
- Manufacturer: [Monteris Medical Corp.](https://devicerts.com/manufacturers/fda-fei-3009970070) (FDA registration: United States)
- Name in the registry: NEUROBLATE SYSTEM
- Device class: Class II (US FDA)
- FDA product code: GEX

## Overview

*AI-generated summary, 2026-09-22. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The NeuroBlate System is a robotic MR-guided laser ablation tool designed specifically for use in the brain. It provides minimally invasive surgical treatment using cooled laser interstitial thermotherapy technology for brain tumors, radiation necrosis, and drug-resistant epilepsy in adult and pediatric patients.

The system is intended for planning and monitoring thermal therapies under MRI visualization, providing MRI-based trajectory planning. It is supplied by Monteris Medical Corp. and has FDA 510(k) clearance with product code GEX. The device is used in a neurosurgical setting and offers precise brain lesion ablation without the invasiveness of open procedures.

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K141983 · decision 2014-08-11 · decision SESE · status: Active

## Recalls

- Z-0228-2015 · Class II · terminated · initiated 2014-10-03: Monteris Medical received a complaint of a separation of the distal sapphire tip from the laser delivery probe.
- Z-0227-2015 · Class II · terminated · initiated 2014-10-03: Monteris Medical received a complaint of a separation of the distal sapphire tip from the laser delivery probe.

## Identifiers

- 510(k) Number: K141983 [FDA 510(k)]
- FDA product code: GEX [FDA 510(k)]

## Classification

- Device class: Class II [FDA 510(k)]
- Regulation: 21 CFR Part 878.4810 [FDA 510(k)]
- Advisory committee: General, Plastic Surgery [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: NeuroBlate System, Monteris Medical Corp. deviCERTS medical device catalogue. https://devicerts.com/devices/neuroblate-system-gex-k141983 (data as of 2026-11-19).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/), [FDA recalls](https://open.fda.gov/apis/device/recall/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-19
- JSON: <https://devicerts.com/devices/neuroblate-system-gex-k141983.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/neuroblate-system-gex-k141983
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
